Monday, September 14, 2026

How South Korea Plans to Lead Northeast Asian Security: Key Insights from President Lee’s Meeting with U.S. Senators

President Lee Jae-myung emphasized strengthening self-reliance in defense while maintaining the US-Korea alliance during a meeting with US senators.

NVP Healthcare Signs Exclusive Supply Deal for NVP-1702 With Brazil’s Marjan Farma at BIO USA

NVP Healthcare signs a deal with Marjan Farma to supply its probiotic NVP-1702 for liver health products in Brazil, aiming for market expansion.

FIFA Investigates Post-Match Violence: What Happened Between Spain and Argentina?

FIFA investigates post-World Cup final violence between Spain and Argentina players, assessing disciplinary actions for rule violations.

Tag: commercialization

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

AI in Healthcare: How SEERS is Revolutionizing Arrhythmia Diagnosis in the UAE

SEERS is advancing the commercialization of AI-based arrhythmia diagnosis in the UAE, expanding its reach in the Middle East market.

Shaperon Accelerates Global Commercialization of NuGel…Secures U.S. Patent, Prepares for Licensing Deal

Sharperon accelerates global commercialization of its key atopic dermatitis treatment, NuGel.

Samsung SDI’s Solid-State Battery: Will Humanoid Robots Lead the Charge by 2027?

Samsung SDI reveals that its first commercialization project for solid-state batteries is likely to be for humanoid applications.

From Preclinical Development to Licensing: JNPMEDI Aims to Accelerate K-Biotech Growth With AI

JNPMEDI emphasizes the need for Korea's biotech sector to enhance global commercialization and reduce clinical trial costs using AI.

Samsung Electronics Launches Dedicated Robotics Division Under CEO to Accelerate Robot Business

Samsung Electronics is launching the RX Business Promotion Office to boost its robotics sector and develop AI-driven autonomous factories.

Samsung Bioepis Signs Teva Deal to Commercialize Opuviz in Canada, Expanding North American Biosimilar Business

Samsung Bioepis partners with Teva to launch ophthalmology biosimilar Opuviz in Canada, enhancing access to treatments for patients.

China’s Fosun Pharma invests $27.5 million in AriBio, boosting optimism for Korean Alzheimer’s drug

Fosun Pharma invests $27.5 million in South Korea's AriBio, boosting its Alzheimer’s drug development and global commercialization efforts.

Top 10 Breakthrough Research Projects from the 2026 UST Proposal Challenge

UST's Proposal Challenge showcased innovative student research aimed at solving social issues, with awards for top proposals in various fields.

Stem Cell Therapies Face Long Road to Market Despite Decades of Promise

Stem cell therapies show promise for treating diseases, but face significant commercialization challenges, including quality control and funding.

Samjin Pharmaceutical and Aribio Lab Form Vaccine Partnership to Advance Joint Development and Commercialization

Samjin Pharmaceutical partners with Aribio Lab to develop and commercialize vaccines, enhancing market adoption and R&D capabilities.

U.S., Japan and China Advance Stem Cell Commercialization While Korea Works to Close Gaps

The global stem cell therapy market is rapidly growing, but South Korea faces challenges in commercialization compared to the U.S. and Japan.

GF Fermentech Showcases Synthetic Biology CDMO Platform at SynBioBeta 2026

GF Fermentech showcased its CDMO platform at SynBioBeta 2026, emphasizing rapid commercialization and advanced production technologies.

HLB Group Appoints Yang Eun-young President of Bio Business Development Division

HLB Group appoints Yang Eun-young as President of Bio Business Development, focusing on global partnerships and commercialization strategies.

Why 20 Years of Stem Cell Therapy Research Still Lacks Proven Results

Stem cell therapy shows promise but faces hurdles in clinical applications and approvals, with few successful treatments available.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.